A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine

Edward M. Newman, Robert J. Morgan, Shivaani Kummar, Jan H. Beumer, M. Suzette Blanchard, Christopher Ruel, Anthony B. El-Khoueiry, Mary I. Carroll, Jessie M. Hou, Chun Li, Heinz J. Lenz, Julie L. Eiseman, James H. Doroshow

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint Dive into the research topics of 'A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences